Pulmonary embolism diagnosis study
- Conditions
- Pulmonary embolism (PE)Circulatory System
- Registration Number
- ISRCTN65486961
- Lead Sponsor
- Queen Elizabeth II Health Science Centre (Nova Scotia) (Canada)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 1530
Consecutive adult patients (18 years and older) of either sex, presenting with symptoms or signs suspected by a physician of being caused by acute pulmonary embolism (acute onset of new or worsening shortness of breath, chest pain, hemoptysis, presyncope or syncope) will be potentially eligible for this study.
1. Deep vein thrombosis or pulmonary embolism within the previous 3 months
2. No worsening of the severity of pulmonary symptoms within the previous 2 weeks
3. Use of therapeutic doses of parenteral anticoagulants for greater than 48 hours
4. Co-morbid condition making life expectancy less than 3 months
5. Contradiction to contrast media
6. A need for long-term use of anticoagulants
7. Pregnancy
8. Age less than 18 years
9. Refusal to give informed consent
10. Geographic inaccessibility to follow-up
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method